1887

Journal of Medical Microbiology logo

Volume 62, Issue 9

infections in South East Scotland: mortality and recurrence in a region without PCR ribotype 027 Open Access

Abstract

Three hundred and thirty-five patients with laboratory-confirmed infections (CDIs) were studied for epidemiological features, clinical presentation and laboratory markers. They were followed up for 1 year to determine recurrence and mortality. Four hundred and thirty-two episodes were recorded. One year mortality was 41.8 % of which CDI was listed on 20 % of the death certificates. One year recurrence rate was 22.9 %. PCR ribotype 001 was the commonest epidemiological type and ribotype 027 was not detected. High total leucocyte count and low albumin were significantly associated with mortality, as was the absence of a GI-invasive procedure in the 12 weeks preceding CDI diagnosis, probably due to patients being unfit for the procedure. No association with acid suppressants, deletion in the anti-sigma factor or vancomycin-resistant enterococcus/methicillin-resistant co-infection was detected. One year mortality was higher in patients who developed recurrent infections (<0.001). Differences in ribotype were observed in 2.3 %, 11.11 %, 20 % and 32.4 % isolates with time intervals between sampling of 0–20, 21–40, 41–60 and >60 days, respectively, suggesting that the arbitrary cut-off of 28 days to call a repeat infection a reinfection may not be correct in some cases.

  • Received:
  • Accepted:
  • Published Online:
© 2013 SGM
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.061093-0
2013-09-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/9/1468.html?itemId=/content/journal/jmm/10.1099/jmm.0.061093-0&mimeType=html&fmt=ahah

References

  1. Abou Chakra C. N., Pepin J., Valiquette L. 2012; Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review. PLoS ONE 7:e30258 [View Article][PubMed]
     [Google Scholar]
  2. Alonso C. D., Treadway S. B., Hanna D. B., Huff C. A., Neofytos D., Carroll K. C., Marr K. A. 2012; Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 54:1053–1063 [View Article][PubMed]
     [Google Scholar]
  3. Andrews C. N., Raboud J., Kassen B. O., Enns R. 2003; Clostridium difficile-associated diarrhea: predictors of severity in patients presenting to the emergency department. Can J Gastroenterol 17:369–373[PubMed]
     [Google Scholar]
  4. Anonymous 2006; Deaths involving Clostridium difficile: England and Wales,1999–2004. Health Statistics Quarterly Summer 3056–60
     [Google Scholar]
  5. Arvand M., Hauri A. M., Zaiss N. H., Witte W., Bettge-Weller G. 2009; Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany. Euro Surveill 14:19403[PubMed]
     [Google Scholar]
  6. Baldan R., Cavallerio P., Tuscano A., Parlato C., Fossati L., Moro M., Serra R., Cirillo D. M. 2010; First report of hypervirulent strains polymerase chain reaction ribotypes 027 and 078 causing severe Clostridium difficile infection in Italy. Clin Infect Dis 50:126–127 [View Article][PubMed]
     [Google Scholar]
  7. Barbut F., Richard A., Hamadi K., Chomette V., Burghoffer B., Petit J. C. 2000; Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38:2386–2388[PubMed]
     [Google Scholar]
  8. Bauer M. P., Notermans D. W., van Benthem B. H., Brazier J. S., Wilcox M. H., Rupnik M., Monnet D. L., van Dissel J. T., Kuijper E. J. ECDIS Study Group 2011; Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377:63–73 [View Article][PubMed]
     [Google Scholar]
  9. Bloomfield M. G., Sherwin J. C., Gkrania-Klotsas E. 2012; Risk factors for mortality in Clostridium difficile infection in the general hospital population: a systematic review. J Hosp Infect 82:1–12 [View Article][PubMed]
     [Google Scholar]
  10. Brazier J. S. 1993; Role of the laboratory in investigations of Clostridium difficile diarrhea. Clin Infect Dis 16:Suppl 4S228–S233 [View Article][PubMed]
     [Google Scholar]
  11. Cadena J., Thompson G. R. III, Patterson J. E., Nakashima B., Owens A., Echevarria K., Mortensen E. M. 2010; Clinical predictors and risk factors for relapsing Clostridium difficile infection. Am J Med Sci 339:350–355[PubMed]
     [Google Scholar]
  12. Carter G. P., Douce G. R., Govind R., Howarth P. M., Macin K. E., Spencer R. J., Buckley A. M., Antunes A., Kotsanas D., Jenkin G. A., Dupuy B., Rood J. I., Lyras D. 2011; The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog 7:e1002317. [View Article][PubMed]
     [Google Scholar]
  13. Chang K., Kreuziger L. M., Angell K., Young J. A., Ustun C. 2012; Recurrence of Clostridium difficile infection after total colectomy in an allogeneic stem cell transplant patient. Bone Marrow Transplant 47:610–611 [View Article][PubMed]
     [Google Scholar]
  14. Choi H. K., Kim K. H., Lee S. H., Lee S. J. 2011; Risk factors for recurrence of Clostridium difficile infection: effect of vancomycin-resistant enterococci colonization. J Korean Med Sci 26:859–864 [View Article][PubMed]
     [Google Scholar]
  15. Curry S. R., Marsh J. W., Muto C. A., O'Leary M. M., Pasculle A. W., Harrison L. H. 2007; tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol 45:215–221 [View Article][PubMed]
     [Google Scholar]
  16. Das R., Feuerstadt P., Brandt L. J. 2010; Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with Clostridium difficile-associated disease. Am J Gastroenterol 105:2040–2049 [View Article][PubMed]
     [Google Scholar]
  17. Dharmarajan T., Sipalay M., Shyamsundar R., Norkus E., Pitchumoni C. 2000; Co-morbidity, not age predicts adverse outcome in Clostridium difficile colitis. World J Gastroenterol 6:198–201[PubMed]
     [Google Scholar]
  18. Eyre D. W., Walker A. S., Wyllie D., Dingle K. E., Griffiths D., Finney J., O’Connor L., Vaughan A., Crook D. W. other authors 2012; Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis 55:Suppl 2S77–S87 [View Article][PubMed]
     [Google Scholar]
  19. Fekety R., McFarland L. V., Surawicz C. M., Greenberg R. N., Elmer G. W., Mulligan M. E. 1997; Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 24:324–333 [View Article][PubMed]
     [Google Scholar]
  20. Goldenberg S. D., French G. L. 2011; Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J Infect 62:355–362 [View Article][PubMed]
     [Google Scholar]
  21. Goorhuis A., Debast S. B., Dutilh J. C., van Kinschot C. M., Harmanus C., Cannegieter S. C., Hagen E. C., Kuijper E. J. 2011; Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin Infect Dis 53:860–869 [View Article][PubMed]
     [Google Scholar]
  22. Gujja D., Friedenberg F. K. 2009; Predictors of serious complications due to Clostridium difficile infection. Aliment Pharmacol Ther 29:635–642 [View Article][PubMed]
     [Google Scholar]
  23. Hall W. H., Ramachandran R., Narayan S., Jani A. B., Vijayakumar S. 2004; An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 4:94 [View Article][PubMed]
     [Google Scholar]
  24. Hardt C., Berns T., Treder W., Dumoulin F. L. 2008; Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein. World J Gastroenterol 14:4338–4341 [View Article][PubMed]
     [Google Scholar]
  25. Hensgens M. P., Goorhuis A., Dekkers O. M., van Benthem B. H., Kuijper E. J. 2013; All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study. Clin Infect Dis 56:1108–1116 [View Article][PubMed]
     [Google Scholar]
  26. HPA 2008 Clostridium Difficile Infection: How to Deal with the Problem London: Department of Health;
     [Google Scholar]
  27. Kamboj M., Khosa P., Kaltsas A., Babady N. E., Son C., Sepkowitz K. A. 2011; Relapse versus reinfection: surveillance of Clostridium difficile infection. Clin Infect Dis 53:1003–1006 [View Article][PubMed]
     [Google Scholar]
  28. Knetsch C. W., Hensgens M. P., Harmanus C., Van Der Bijl M. W., Savelkoul P. H., Kuijper E. J., Corver J., Van Leeuwen H. C. 2011; Genetic markers for Clostridium difficile lineages linked to hypervirulence. Microbiology 157:3113–3123 [View Article][PubMed]
     [Google Scholar]
  29. Labbé A. C., Poirier L., Maccannell D., Louie T., Savoie M., Béliveau C., Laverdière M., Pépin J. 2008; Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 52:3180–3187 [View Article][PubMed]
     [Google Scholar]
  30. McDonald L. C., Coignard B., Dubberke E., Song X., Horan T., Kutty P. K. Ad Hoc Clostridium difficile Surveillance Working Group 2007; Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 28:140–145 [View Article][PubMed]
     [Google Scholar]
  31. Morrison R. H., Hall N. S., Said M., Rice T., Groff H., Brodine S. K., Slymen D., Lederman E. R. 2011; Risk factors associated with complications and mortality in patients with Clostridium difficile infection. Clin Infect Dis 53:1173–1178 [View Article][PubMed]
     [Google Scholar]
  32. O'Neill G. L., Ogunsola F. T., Brazier J. S., Duerden B. I. 1996; Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile . Anaerobe 2:205–209 [View Article]
     [Google Scholar]
  33. Pépin J., Valiquette L., Gagnon S., Routhier S., Brazeau I. 2007; Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Am J Gastroenterol 102:2781–2788 [View Article][PubMed]
     [Google Scholar]
  34. Persson S., Jensen J. N., Olsen K. E. 2011; Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdC . J Clin Microbiol 49:4299–4300 [View Article][PubMed]
     [Google Scholar]
  35. Reddy S., Taori S., Poxton I. R. 2010; Changes in laboratory and clinical workload for Clostridium difficile infection from 2003 to 2007 in hospitals in Edinburgh. Clin Microbiol Infect 16:340–346 [View Article][PubMed]
     [Google Scholar]
  36. Spencer R. C. 1998; Clinical impact and associated costs of Clostridium difficile-associated disease. J Antimicrob Chemother 41:Suppl 35–12 [View Article][PubMed]
     [Google Scholar]
  37. Stubbs S. L., Brazier J. S., O’Neill G. L., Duerden B. I. 1999; PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37:461–463[PubMed]
     [Google Scholar]
  38. Tal S., Gurevich A., Guller V., Gurevich I., Berger D., Levi S. 2002; Risk factors for recurrence of Clostridium difficile-associated diarrhea in the elderly. Scand J Infect Dis 34:594–597[PubMed] [CrossRef]
     [Google Scholar]
  39. Verdoorn B. P., Orenstein R., Rosenblatt J. E., Sloan L. M., Schleck C. D., Harmsen W. S., Nyre L. M., Patel R. 2010; High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity. Diagn Microbiol Infect Dis 66:24–28[PubMed] [CrossRef]
     [Google Scholar]
  40. Walk S. T., Micic D., Jain R., Lo E. S., Trivedi I., Liu E. W., Almassalha L. M., Ewing S. A., Ring C. other authors 2012; Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 55:1661–1668 [View Article][PubMed]
     [Google Scholar]
  41. Wilcox M. H., Fawley W. N., Settle C. D., Davidson A. 1998; Recurrence of symptoms in Clostridium difficile infection–relapse or reinfection?. J Hosp Infect 38:93–100 [View Article][PubMed]
     [Google Scholar]
  42. Wilson V., Cheek L., Satta G., Walker-Bone K., Cubbon M., Citron D., Gerding D. N., Llewelyn M. J. 2010; Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis 50:e77–e81 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.061093-0
Loading
Clostridium difficile infections in South East Scotland: mortality and recurrence in a region without PCR ribotype 027
J. Med. Microbiol. 62, 1468 (2013); https://doi.org/10.1099/jmm.0.061093-0
/content/journal/jmm/10.1099/jmm.0.061093-0
/content/journal/jmm/10.1099/jmm.0.061093-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error